Schedule 13D ownership disclosure

UROVANT SCIENCES LTD

Security class unavailable · CUSIP: G9381B108

Event date: 2018-10-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,703,669
Percent of class
75.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-18-000544
Form type
SC 13D
Filer
Urovant Sciences Ltd.
CIK
CIK 1740547
Filed
Oct 10, 2018
Reporting period
Oct 01, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub